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Abstract
Background: Paediatric poisoning is a common presentation to emergency departments worldwide. There is a
paucity of data on the role of liquid chromatography-tandem mass spectrometry (LC-MS/MS), in the management
of paediatric poisoning in low-and middle-income countries (LMICs). In high-income countries, most studies are
retrospective, and few include children.
Objective: The study describes the prevalence of liquid chromatography-tandem mass spectrometry confirmed
paediatric poisoning at Red Cross War Memorial Children’s Hospital, Cape Town, South Africa.
Methods: Children admitted with suspected poisoning between 1 January 2017 and 31 December 2017, were
recruited. All patients had a urine and/or blood sample sent for LC-MS/MS toxicology. Data collected included
demographic data, clinical features, investigations, management, outcome and social interventions.
Results: One hundred fifty-two children, with median age of 39 (IQR 25–61) months were enrolled of which 128
(84%) were poisoning cases. Of the 128 poisoning cases, 88 (69%) presented with a history of ingesting a known
substance, 16 (12%) an unknown substance and 24 (19%) were cases of occult poisoning. LC-MS/MS was able to
identify a substance in 92% of the cases of occult poisoning. In those who had presented with a seemingly known
substance, LC-MS/MS found a different substance in 15 cases. LC-MS/MS was also able to detect multiple drugs in
40 patients. Of the poisoning cases, six (5%) cases were attempted homicide cases and 5 (4%) cases were
attempted suicide cases. No children died. Individualized social interventions were instituted in poisoning cases.
Emergency placement safety reasons was required in 6 children.
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Conclusion: When the limitations are known, LC-MS/MS is useful in identifying cases of occult poisoning,
identifying patients who have ingested multiple substances and/or an unknown substance and when targeted
towards child protection. As LC-MS/MS is an expensive test, it should be used judiciously in LMICs.
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“Key messages” box
Section 1: what is already known on this subject
The use of investigations in paediatric poisoning is con-
troversial. There is a paucity of prospective data on the
use of LC-MS/MS in paediatric poisoning in LMICS,
where resources are constrained and risk factors for poi-
soning such as neglect and child abuse are high.
Section 2: what this study adds
LC-MS/MS is beneficial in the paediatric patient who
presents with occult poisoning or has ingested multiple
and/or unknown substances. Requesting clinicians need
to be aware of its shortfalls. In high risk settings, it can
be utilized in community toxicovigilance and child pro-
tection. Due to its expense, a protocol needs to be devel-
oped for its judicial use in LMICS.
Background
Paediatric poisoning is a common presentation to emer-
gency departments worldwide [1, 2]. Though it has a
good prognosis, it is an important cause of both morbid-
ity and mortality [1, 3]. In 2016 it was responsible for 6,
268,554 disability adjusted life years (DALYs) globally,
with children less than 15 years accounting for 45% of
these DALYs [4]. In a study done in South Africa, poi-
soning was responsible for 5.7% of all hospital admis-
sions [2]. While, a retrospective patient folder review
carried out at a hospital in Johannesburg, indicated that
toxin ingestion was responsible for 17% of the admis-
sions in to the paediatric intensive care unit [5].
In 2016, poisoning resulted in 31,400 unintentional
deaths globally in children less than 15 years of age [6].
The death rate of poisoning was higher in low-and mid-
dle income countries (LMICs), with LMICs accounting
for 69% of the deaths that year [6]. Despite the higher
death rates in LMICs, data on the incidence of paediatric
poisoning is more accurate in high-income countries
(HICs) where poison control centers have been estab-
lished and poisoning registries are kept [1].
Risk factors for poisoning include age, sex and envir-
onmental factors such as neglect [3, 7]. Child abuse, in
particular neglect, is a big problem in low resource set-
tings such as in Africa, especially in the under-5 popula-
tion [8–11]. This under-5 population is the age group
with the highest incidence of poisoning [1–3, 7, 12–14].
In LMICs, neglect may present as accidental poisoning
as children are often left unsupervised, while child abuse
may present as intentional or occult poisoning [15–17].
The role of investigations in poisoning is controversial
but may be of benefit in occult poisoning, where it is dif-
ficult to confirm the presence and cause of poisoning.
Point-of-care urine drug screen (POCUDS) testing is
cost effective and readily available, able to give immedi-
ate results but has several disadvantages, such as, a high
false positive rate; can only screen for a limited number
of drugs; inability to quantify the drug; inability to name
the drug, as it can only identify the drug class and the
risk of false negatives if the drug in question is below
the threshold cut-off for detection [18–22].
Liquid chromatography tandem mass spectrometry
(LC-MS/MS) on the other hand, is a good confirmatory
test [18, 20]. Unlike POCUDS, it has a higher sensitivity
and specificity and has other advantages, such as, the in-
creased breadth of substances that it can detect and its
ability to identify and quantify drugs and their metabo-
lites by name, and not just by the drug class [18, 21, 23,
24]. The main problem with LC-MS/MS, however, is
that it is expensive and may have a long turnaround
time [18, 19, 21].
Most of the studies done on the use of LC-MS/MS in
poisoning have been done in a retrospective manner and
in high-income settings [21]. Additionally, few of these
studies have included children. The role of LC-MS/MS
in LMICs, where the number of cases of child abuse and
neglect are high and the resources to manage poisoned
children are severely constrained, is not clear. Its use
may be able to assist in identifying high-risk children in
households that need social (child protection)
interventions.
This study aims to describe the prevalence of LC-MS/
MS confirmed poisoning in children who presented to a
LMIC paediatric tertiary hospital over a period of a year,




The study was done at Red Cross War Memorial Chil-
dren’s Hospital (RCWMCH), a public children’s hospital
that provides secondary and tertiary health care services
to children less than 13 years, living in urban, peri-urban
and informal settlements. The hospital manages
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approximately 35,000 non-trauma emergency care
patient-visits each year. A substantial proportion of the
patients come from extremely poor and marginalized
communities [25]. The children in the catchment area of
RCWMCH are not only vulnerable because of poverty
but also because of the increase in substance abuse in
formal and informal settlements in the Western Cape
Province of South Africa [8, 26, 27].
Study design
The study prospectively enrolled patients with suspected
poisoning admitted to the RCWMCH from the 1st of
January 2017 to the 31st of December 2017, in a cross-
sectional design.
Participants
All patients admitted at RCWMCH with suspected poi-
soning were eligible for recruitment into the study if
their legal guardians were willing to sign consent for
them to be included. Patients who ingested corrosives
requiring surgical intervention were excluded from the
study.
Data collection and procedures
After consent, data on demographic information, clin-
ical presentation and results of investigations done by
the attending clinician were taken, history was taken
from the caregiver to establish possible causes of poi-
soning. The patient was followed up over the period
of admission and management including clinical out-
comes was recorded. The Poisoning Severity Score
(PSS) was used to grade the severity of poisoning at
admission (Table 1) [28].
Toxicology investigation
A urine sample from eligible participants was sent to the
laboratory for LC-MS/MS to establish the cause of poi-
soning. In addition, the attending clinician and labora-
tory were consulted for any leftover blood specimen
after laboratory tests ordered by the attending clinician
were completed that could likewise be tested on LC-MS/
MS. Study participants were not bled solely for the
study.
The LC-MS/MS unit used for this study was the, AB
Sciex 3200 QTRAP (© 2013 AB Sciex Pty. Ltd., AB
Sciex, 500 Old Connecticut Path, Framingham MA
01701–4574) unit, housed in the Division of Clinical
Pharmacology, University of Cape Town, Groote Schuur
Hospital, Cape Town. At the time of the study it had a
library of 120 prescription drugs, over the counter medi-
cines, illicit drugs and some of their metabolites. The li-
brary did not include pesticides or herbal compounds
used in traditional medicines.
Due to the limited availability of the LC-MS/MS
unit, samples were tested in batches. Once collected,
samples were registered and transported to the la-
boratory where they were stored at 4 °C until analysis.
The median turnaround time (TAT) for obtaining a
result was 5 (interquartile range, (IQR) 3–7) days for
urine LC-MS/MS and 6 (IQR 4–7) days for blood
LC-MS/MS. A total of five patients had LC-MS/MS
results within 24 h.
Trained personnel ran the samples and interpreted the
results. For quality control, internal standards were
added to each sample as part of the sample preparation.
Each run included blanks, as well as positive and nega-
tive controls to ensure accurate results [29, 30].
In order to observe for possible substance degradation,
compound stability tests were done on the LC-MS/MS
unit. A commercially obtained control, a system suitabil-
ity test (SST) (Restek® Corporation) was run daily. The
kit contains 8 compounds of known concentrations. The
peak areas of each compound were observed to confirm
that the instrument performance and sensitivity were
optimal and at the same time to observe for possible
compound degradation, by comparing these areas to
previously acquired data.
As poisoning is defined by the presence of clinical
(somatic and/or mental) manifestations, or laboratory
and/or electrocardiographic abnormalities resulting from
exposure to a substance that can lead to harmful clinical
effects [31], once all the toxicology investigations and
clinical presentations were analysed, the authors
classified the cases into one of three groups: substance-
intake-unlikely, substance-intake-likely or substance-
intake- unclear. The substance-intake-unlikely group
were patients whose clinical presentation could be ex-
plained by an alternative medical diagnosis and were,
therefore, not considered poisoning cases even though
they were admitted as cases of suspected poisoning. The
substance-intake-unclear group were patients whose
clinical presentation could not be explained by a medical
diagnosis and whose toxicology investigation results
were not indicative of poisoning. The substance-intake-
likely group were those patients whose clinical presenta-
tion could be explained by a toxic substance (even in the
absence of an LC-MS/MS identified substance) and were
Table 1 PSS grading
Grade Description
None No symptoms or signs related to poisoning
Minor Mild, transient and spontaneously resolving symptoms
Moderate Pronounced or prolonged symptoms
Severe Severe or life-threatening symptoms
Fatal Death
PSS Poisoning severity score. From Hans E Persson et al., 1998, Poisoning
Severity Score. Grading of Acute Poisoning
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therefore considered poisoning cases, even in the ab-
sence of symptoms.
Irrespective of laboratory results, for the purposes of
our study, poisoning cases were also clinically divided by
the authors into three groups: substance known (history
of exposure to a known substance), substance unknown
(history of exposure to an unknown substance) and oc-
cult poisoning (no history of poisoning, but clinical pres-
entation in keeping with poisoning).
Data analysis
Statistical analyses were done using STATA® 14.0
(StataCorp LLC, College Station, Texas, USA). The
demographic characteristics and clinical findings at pres-
entation were tabulated to provide a background de-
scription of the study population. All substances that
tested positive with LC-MS/MS were described. Percent-
ages and their 95% confidence intervals in outcomes of
interest were used to depict proportions of categorical
variables while medians with interquartile ranges were
used to summarise continuous variables. The χ2 test or
Fisher’s exact test were used to assess the strength of as-
sociation between two categorical variables as appropri-




A total of 228 cases of suspected poisoning were
screened of which 152 were included (Fig. 1). The me-
dian age of the included children was 39 (IQR 25–61)
months, of whom 86 (56%) were male and 113 (74%)
were below 5-years-of age (Table 2).
Toxicology results
A total of 146 (96%) urine samples from the 152
study participants were analysed by LC-MS/MS after
six samples were lost due to leakage in transit. For 80
(53%) participants, there was sufficient left-over blood
specimen in the laboratory for LC-MS/MS testing.
This included the six participants whose urine sam-
ples had been lost to leakage. Altogether, in 89/152
(59%) participants a substance was detected. In 16
(18%) of these the detected substances were iatrogenic
secondary to administration of in-hospital care or
therapy given at home. After discounting the iatro-
genic substances or medicines given at home 73 of
152 (48, 95% CI 40–56%) participants had a substance
detected by LC-MS/MS.
In total, 128 (84%) of the children, 71 (55%) in
whom a substance was detected on LC-MS/MS, were
classified as genuine cases of poisoning (substance-in-
take-likely), while 15 (10%) of the 152 were classified
as unlikely to have been poisoned (substance-intake-
unlikely). In nine (6%) of the children it was not clear
whether poisoning had taken place or not (substance-
intake-unclear).
Despite being classified as genuine cases of poisoning,
57 (45%) of the 128 substance-intake-likely children did
not have a causative substance identified via LC-MS/MS
and 49 (38%) children had no substance identified and
eight (6%) had iatrogenic substances identified. The me-
dian TAT for the 57, who were substance-intake-likely
cases but in whom the LC-MS/MS was negative, was 5
(IQR 3–9) days for urine LC-MS/MS and 5 (IQR 4–9)
days for blood. TAT of the 71 poisoning cases that had
positive LC-MS/MS was 5 (IQR 2–7) days for urine and
6 (IQR 4–7) days for blood.
In 26 (20%) of the substance-intake-likely group in
whom no substance was detected, the suspected sub-
stance was not in the LC-MS/MS reference library used.
Of these, 17/26 (65%) were pesticides (11 rat ‘poison’, 4
‘cockroach poison’, 1 ‘tick poison’ and 1 undefined
pesticide).
There were eight organophosphate poisonings cases in
the substance-intake-likely group. In two of the eight or-
ganophosphate poisonings, LC-MS/MS detected other
substances (bromazepam and diphenhydramine),
ingested by the same patients. Likewise, in one of the
four cases of iron poisonings, trimethoprim was con-
comitantly identified by LC-MS/MS. Eight patients who
had ingested hydrocarbons, three ethanol ingestions, two
turpentine, and one each of petrol, eucalyptus oil and
paraffin ingestion, had no additional substances detected
by LC-MS/MS.
Five (4%) patients in the substance-intake-likely group
presented with a history of ingesting an unknown sub-
stance, and the identity of the unknown substance was
not identified via LC-MS/MS. Cannabis was detected via
LC-MS/MS in a tablet brought by one of these patients
but could not be confirmed in the patient’s samples.
Nine patients in the substance-intake-likely group pre-
sented after ingesting a substance found in the LC-MS/
MS library and yet the substance was not detected by
LC-MS/MS, despite seven patients being symptomatic
from the suspected substance. Four of the nine patients
had both blood and urine LC-MS/MS done, while five
had only urine LC-MS/MS done. The drugs that were
not detected were the following, clonazepam, diazepam,
lorazepam, phenytoin, alprazolam, cannabis, antiretrovir-
als (tenofovir/emtricitabine/efavirenz), chlorpromazine
and tricyclic antidepressant. Six of the patients had
vomiting induced by the care giver in an attempt to de-
contaminate. Furthermore, two of these patients received
charcoal before the LC-MS/MS was done (one case of
tricyclic antidepressant toxicity and one case of chlor-
promazine ingestion). The median TAT for these nine
patients was 7 days with a range of 1–13 days.
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Of the 15 patients, in the substance-intake-unlikely
group, LC-MS/MS detected no substances in eight
(53%) and identified iatrogenic medicines in seven
(47%). Of the nine substance-intake-unclear patients,
one patient had a positive result due to iatrogenic
medicines and two had positive results, but the
drugs identified could not explain the clinical
presentation.
Presenting history versus LC-MS/MS results in poisoning
cases (substance-intake-likely)
When the 128 children in the substance-intake-likely
group was further analysed according to the history ob-
tained from the caregiver, 24 (19%) participants had no
history of exposure to a substance (occult poisoning).
(Fig. 2) In those who had occult poisoning, the suspicion
of poisoning came from the clinician’s examination find-
ings, and/or investigations done by the attending clin-
ician. The substance detection rate of LC-MS/MS, after
removing iatrogenic medicines, was then analysed in
three different groups, known substance, unknown sub-
stance and occult poisoning. (Fig. 2).
In children with occult poisoning, LC-MS/MS was
able to identify the substance in 22/24 (92%) compared
to 42/88 (48%) when a guardian reported ingestion of a
known substance (p = < 0.0001), and 7/16 (44%) when a
guardian reported ingestion of an unknown substance (p
value = 0.003) (Fig. 2).
In the 22 (92%) cases of occult poisoning, in which LC-
MS/MS identified a substance, the substance identified
was in keeping with the clinical presentation in 20/22
(91%). The two patients, in whom LC-MS/MS identified a
substance not in keeping with the clinical presentation,
concomitant organophosphate poisoning was identified by
alternative means. In these two organophosphate cases
LC-MS/MS identified a substance that would have other-
wise been missed. All 15 patients who had presented with
an unknown substance and 23 (96%) of the 24 cases of oc-
cult poisoning had neurological symptoms.
In the patients who reported ingesting a seemingly
‘known’ substance, the substance found on LC-MS/MS
was different in 15/88 (17%) patients. In these 15 cases,




Age < 1 year 14 (9%)
1–5 years 99 (65%)
> 5–12 years 31 (21%)
> 12 years 8 (5%)
Housing Formal 96 (63%)
Informal 39 (26%)
Unknown 17 (11%)
Fig. 1 Study participant flow chart. LC-MS/MS- liquid chromatography tandem mass spectrometry
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six were asymptomatic, while four had symptoms con-
sistent with the substance found on LC-MS/MS.
Overall, 18/128 (14%) cases of poisoning would have
been missed had LC-MS/MS not been used in this
study.
Causes of poisoning
In 106/128 (83%) of the cases, poisoning was uninten-
tional. There were however 6/128 (5%) cases of
attempted homicide and 5/128 (4%) of attempted suicide
(Table 3).
Of the six attempted homicides, two cases involved
siblings from a family that had three deaths due to
the same organophosphate poisoning event. In one of
the patients who had been given traditional medi-
cines, norfluoxetine, trimethoprim and diphenhydra-
mine were detected by LC-MS/MS. Four of six
children given substances intentionally by adults
Fig. 2 Number and proportion of substance detection rates on LC-MS/MS in substance-intake-likely group. LC-MS/MS liquid chromatography
tandem mass spectrometry
Table 3 Causes of poisoning (Intent), n = 128
Intention Frequency (N = 128)
Unintentional Self 99 (77.3%)
Caregiver medication error 1 (0.8%)
Traditional medicine 3 (2.3%)
Iatrogenic 3 (2.3%)
Intentional Attempted homicide 6 (4.7%)
Caregiver/adult but not attempted homicide 6 (4.7%)
Attempted suicide 5 (3.9%)
Self but not suicide attempt 1 (0.8%)
Undetermined 4 (3.1%)
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received drugs of abuse- two received cannabis, one
received methamphetamine and the other ethanol.
The other two patients, presented with neurological
symptoms, and the substances administered could not
be identified.
Drugs identified by LC-MS/MS
LC-MS/MS was able to identify a total 45 different drugs
after removal of iatrogenic medicines and medicines
given at home (Fig. 3). In the 128 substance-intake-likely
cases, LC-MS/MS identified 140 substances. The most
common causative group identified by LC-MS/MS was
antihistamines found in 24 (19%) patients, followed by
opiates in 23 (18%) and antipsychotics in 17 (13%). The
most common drugs were chlorpheniramine and halo-
peridol found in 9 (7%) patients each. LC-MS/MS was
able to identify multiple drugs in 40 (31%) of the
substance-intake likely group.
Comparison of urine and blood LC-MS/MS results
Seventy-four (74) patients had both urine and blood
samples analysed on LC-MS/MS. Urine and blood LC-
MS/MS yielded the exact same result in 48 (65%) pa-
tients (Table 4). In 18 (24%) of the participants with
paired samples, more substances were detected in urine
but not in blood, while in 4 (5%) samples, more sub-
stances were detected in blood but not urine.
Clinical systems involved in the poisoning cases
Of the 71 positive LC-MS/MS results in the substance-
intake-likely group, the substances identified by LC-MS/
MS were in keeping with the clinical presentation in 55/
71 (77%) participants. Nine (13%) of the 71 positive LC-
MS/MS cases in the substance- likely-group were
asymptomatic even though a substance was detected by
LC-MS/MS.
The most common system involved was neurological,
found in 88 (69%) of the substance-intake-likely cases
followed by gastrointestinal found in 49 (38%), cardio-
vascular in 26 (20%) and 22 (17%) were asymptomatic.
Of the 49 that had gastrointestinal symptoms 24 (49%)
had the presence of the confounder of intentional induc-
tion of vomiting by the caregivers using manual induc-
tion, milk and/or saltwater. LC-MS/MS detected a
substance in 58 (66%) out of 88 poisoning cases with
neurological symptoms compared to 13 (33%) of the 40
without neurological symptoms (p < 0.0001).
Substance-intake-likely management and outcome
According to the PSS, most cases were classified as
moderate, 51 (40%), while 12 (9%) were classified as
none and 42 (33%) were minor and therefore required
minimal supportive care. Of the 23 (18%) children with
a PSS severe grade, 10 (8%) required admission to the
Paediatric Intensive Care Unit (PICU). Twenty-nine chil-
dren (23%) were given an antidote and 6 (5%) received
activated charcoal. There were no deaths.
Fig. 3 Drug classes identified by LC-MS/MS. LC-MS/MS: liquid chromatography tandem mass spectrometry
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Individualized social intervention was instituted in all
the patients with removal and emergency placement oc-
curring in six patients. All six attempted homicide cases
were referred for forensic investigation. The mother was
the perpetrator in four of the attempted homicide cases.
LC-MS/MS detected a substance in three of the
attempted homicides. A total of 22 (14%) patients had
an LC-MS/MS result prior to discharge.
Discussion
Our study describes the prevalence of LC-MS/MS-con-
firmed paediatric poisoning in a LMIC setting. LC-MS/
MS was particularly helpful in occult poisoning where it
was able to identify over 90% of the substances, as well
as in identifying multiple substance ingestion. In
addition, our study indicates the urine sample as having
a higher detection rate for identifying potential ingested
substances when compared to a blood specimen. Ac-
cording to the authors’ knowledge, this study is the first
prospective one of its kind done in a LMIC setting.
Similar to previous studies, most of the poisoning
cases were males between the ages of one and 5 years
[1–3, 7, 12–14]. This is likely due to the developmental
stage toddlers are in, that involves curiosity about the
world and a desire to explore it [13, 14].
Previous literature has demonstrated shortfalls with
urine point of care drug screen immunoassay, therefore,
a positive point of care urine drug screen result requires
a confirmatory test, such as mass spectrometry [18, 20–
22]. After excluding iatrogenic medicines and therapy
given prehospital, LC-MS/MS was able to detect sub-
stances in 48% of all study participants and 55% in the
substance-intake-likely cases.
Twenty-six patients in this study reported ingesting a
substance that was not in the library. This was the main
reason for a negative LC-MS/MS result in poisoning
cases, in this study. This indicates that the ability of LC-
MS/MS to detect a substance is limited by the extent of
the LC-MS/MS library available at the time. Notably, the
LC-MS/MS library can be updated and additional drugs/
substances added [18, 19, 21]. The LC-MS/MS used in
this study could detect the presence of various drugs in
concentrations as low as 20 ng/ml. Despite this high sen-
sitivity, nine poisoning cases who had ingested drugs in
the LC-MS/MS library were not detected. The possible
explanations are varied and include, that the concentra-
tion of these drugs in the analysed samples may have
been below the limit of detection of the instrument, ei-
ther due to rapid metabolism or elimination. Six of the
nine patients had vomiting induced by the care givers
which could have led to decontamination, before the pa-
tient could absorb the drug. Notably, two of these pa-
tients were given activated charcoal. Worryingly, the
first was a tricyclic antidepressant overdose, that LC-
MS/MS did not detect. The second was a symptomatic
chlorpromazine ingestion. This ingestion was witnessed,
and the patient was given activated charcoal before the
LC-MS/MS was done. It is possible that LC-MS/MS
may have been limited by failure to detect substances
that are eliminated via the hepatobiliary system which
may not have been detectable in urine, as well as sub-
stances with a short half-life that may have degraded be-
fore sampling or analysis. These reasons are limitations
of LC-MS/MS that the clinician needs to be aware of
when utilising LC-MS/MS. All nine drugs that the LC-
MS/MS failed to identify, and yet were in the LC-MS/
MS library, are excreted in urine except for tenofovir,
which is mainly excreted in faeces. A study done on
sample stability indicated that substance degradation
was dependent upon the type of substance and the
temperature at which a sample is stored [32]. Substances
stored at 25 °C, 4 °C and − 20 °C were later extracted and
analysed at 15, 60 and 90 days and the average relative
peaks on these days were compared with the average
relative peaks at baseline [32]. The study concluded that
the best temperature to store samples is − 20 °C, al-
though even at 4 °C the substances could still be de-
tected even if the peaks were lower [32]. The samples in
our study were stored at 4 °C, and therefore substance
degradation cannot be ruled out.
Table 4 Comparing urine and blood LC-MS/MS positivity rate (N = 74)
LC-MS/MS Result Frequency (%)
No detected substance in urine and blood 27 (36%)
Same substance detected in urine and blood 21 (28%)
Different substance detected in urine and blood 4 (5%)
Substance detected in urine and blood, but more substances found in urine 7 (9%)
Substance detected in urine and blood, but more substances found in blood 3 (4%)
Substance detected in urine but not in blood 11 (15%)
Substance detected in blood but not in urine 1 (1%)
Total 74 (100%)
LC-MS/MS Liquid chromatography tandem mass spectrometry
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There are other substances that the LC-MS/MS could
not detect, and these included: volatile substances such
as hydrocarbons, which require a different method i.e.,
gas mass spectrometry for detection; organophosphates
because they metabolize fast and metals such as iron. As
a result, though a positive LC-MS/MS result is benefi-
cial, a negative LC-MS/MS result does not rule out
poisoning.
Due to circumstantial evidence, such as an open
bottle or missing tablets, the causative agent in paedi-
atric poisoning is generally obtained from history,
which means laboratory investigations to identify the
cause of poisoning is often regarded as not necessary.
However, in our study, LC-MS/MS found that of the
88 poisoning cases that had ingested a seemingly
‘known’ substance, almost a fifth (17%), of the pa-
tients had ingested a different drug from that re-
ported by the caregiver. This has management
implications as the wrong drug level can be requested
from the laboratory and the wrong antidote given
while the right one is delayed.
Most of the studies and reports that look at the causes
of poisoning in children do not highlight multiple drug
exposure as an important cause of poisoning [1, 7, 13,
33]. Veale et al., in a study that included both adults and
children, indicated that only 13.8% of the poisoning
cases had been exposed to multiple drugs [12]. While a
retrospective study done at the same children’s hospital
as our study setting, indicated that less than 10% of the
children who presented with poisoning had been ex-
posed to more than one toxin [3]. Contrary to the previ-
ous mentioned studies, that reported low rates of
multiple drug ingestion in children, in our study, LC-
MS/MS detected 40 (31%) cases of multiple drug inges-
tions further demonstrating the ability of LC-MS/MS in
positively identifying multiple drug ingestions. The use
of laboratory specific drug levels to detect multiple drugs
requires the clinician to request different specific drug
levels to be run, in contrast, LC-MS/MS requires only
one sample to be run to identify multiple drugs and/or
substances. Without LC-MS/MS multiple drug inges-
tions would have been missed in this cohort of children.
However, it is important to note that LC-MS/MS was
not able to differentiate between multiple drugs from a
single medicine with two or more drugs, and that which
involved ingestion of multiple separate drug
formulations.
The most common drug classes found in our study
were antihistamines (19%), opiates (18%), antipsychotics
(13%) antidepressants (12%) and antiepileptics (10%),
while the most common drugs detected on LC-MS/MS
were chlorpheniramine and haloperidol. This may ex-
plain the high frequency (69%) of neurological symp-
toms in the cases with likely substance ingestion.
Historically, agro-based and non-drug chemicals were
the main causes of poisoning in LMICs [1, 3, 7, 33–35].
There is a need to strengthen preventative campaigns in
LMICs as pharmaceuticals are becoming important
causes of poisoning [12, 34].
Traditional medicine use is not uncommon in
LMICs, there have been previous reports of these
medicines being adulterated, as was the case in one
of our patients who ingested traditional medicine and
LC-MS/MS identified norfluoxetine, trimethoprim and
diphenhydramine [24, 36–39].
While, both blood and urine samples can be analysed
by LCMSMS, urine is usually readily available as a non-
invasive specimen with minimal discomfort to children.
Furthermore, unlike in blood, drugs and their metabo-
lites are known to remain in urine for longer (up to 1
week) post last exposure depending on the drug [20, 21,
40]. This gives a greater window of opportunity to still
identify a substance after ingestion, especially when this
is unknown or occult.
It is important to note that the clinical outcome was
not altered using LC-MS/MS, this corresponds to previ-
ous studies, and in our study was because of the long
turnaround time, with a median of 5 (IQR 3–7) days for
urine LC-MS/MS and 6 (IQR 4–7) days for blood [19,
21]. In our study, the turnaround time was prolonged
because the test samples were batched. The other major
limitation of mass spectrometry is its expense [18, 19].
However, as technology has improved, mass spectrome-
ters have become cheaper and faster [18, 23, 29, 41–43].
A study by Caspar et al., demonstrated its value in 24/7
toxicology by analysing 22 drugs and active metabolites
in a qualitative and quantitative manner [30]. In the
study done by Caspar et al., the total run time for a test
was 11min, extrapolated to the emergency care setting,
such run times would enable the clinician to treat the
patient accordingly and in a timely point-of-care manner
[30, 43]. It would also avoid unnecessary treatment pro-
cedures in those that do not require them. The LC-MS/
MS system may also be made more efficient using auto-
mation, this reduces the need for skilled personnel to
run the equipment [18, 21].
LC-MS/MS identified 92% of all cases of occult poi-
soning and the substance identified by LC-MS/MS were
in keeping with the clinical presentation in 91% of the
cases of occult poisoning. There is limited data on the
prevalence of occult poisoning in children especially in
LMICs, in our study, one in five (19%) of the poisoning
cases were due to occult poisoning. Occult poisoning
was more likely if the patient had acute unexplained
neurological symptoms that were not due to an infection
or trauma. This makes LC-MS/MS of value in the area
of child protection, when children may be poisoned
intentionally. Child protection is also required in all
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cases of unintentional poisoning that are due to neglect.
In this study six children required removal from the ad-
verse environment as well as further child protective
measures.
Limitations
Our study is limited by a small sample size which re-
duced our ability to stratify the data further by causes of
poisoning. Furthermore, we were not able to include un-
natural home deaths that presented to the mortuary. As
alluded to earlier, the LC-MS/MS library used did not
contain an exhaustive list of possible substances.
Conclusion
In conclusion, the use of LC-MS/MS in toxicology
screening is novel in the African paediatric population.
It appears to be of greatest value in the paediatric patient
who presents with occult poisoning or has ingested mul-
tiple and/or unknown substances. It was less helpful in
those that had ingested a known single substance unless
the substance found on LC-MS/MS was found to be dif-
ferent. Though a robust test, clinicians need to be aware
of its shortfalls. In high-risk settings, it can be utilized in
community toxicovigilance and child protection. Finally,
the authors could not find guidelines on the use of in-
vestigations, in particular LC-MS/MS, in LMICs, and be-
cause LC-MS/MS is an expensive test, we recommend
that a protocol for its judicial use in LMICs be
developed.
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